Peptide TaY Attenuates Inflammatory Responses by Interacting with Myeloid Differentiation 2 and Inhibiting NF-κB Signaling Pathway
Molecules · 2024
DOI: 10.3390/molecules29204843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Junyong Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Feed Biotechnology, State Key Laboratory of Animal Nutrition and Feeding, College of Animal Science and Technology, China Agricultural …. Hauptthemen laut MEDLINE: Signal Transduction, NF-kappa B, Inflammation, Lipopolysaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R & D projects of China, National Natural Science Foundation of China, China Agricultural University-Jilin Xide Agricultural and Animal Husbandry Company Science and Technology Cooperation Program.
Abstract (Originalsprache)
A balanced inflammatory response is crucial for the organism to defend against external infections, however, an exaggerated response may lead to detrimental effects, including tissue damage and even the onset of disease. Therefore, anti-inflammatory drugs are essential for the rational control of inflammation. In this study, we found that a previously screened peptide TaY (KEKKEVVEYGPSSYGYG) was able to inhibit the LPS-induced RAW264.7 inflammatory response by decreasing a series of proinflammatory cytokines, such as TNF-α, IL-6, and nitric oxide (NO). To elucidate the underlying mechanism, we conducted further investigations. Western blot analysis showed that TaY reduced the phosphorylation of key proteins (IKK-α/β, IκB-α,NF-κB (P65)) in the TLR4-NF-κB signaling pathway and inhibited the inflammatory response. Furthermore, molecular docking and molecular dynamic simulations suggested that TaY binds to the hydrophobic pocket of MD2 through hydrogen bonding and hydrophobic interactions, potentially competing with LPS for MD2 binding. Collectively, TaY is a promising candidate for the development of novel therapeutic strategies against inflammatory disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Feed Biotechnology, State Key Laboratory of Animal Nutrition and Feeding, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.
ORCID-Profile: Junyong Wang, Zaheer Abbas
Förderung
- National Key R & D projects of China
- National Natural Science Foundation of China
- China Agricultural University-Jilin Xide Agricultural and Animal Husbandry Company Science and Technology Cooperation Program
- National Key R & D projects of China
Zitieren
APA
Wang, J., Zhou, Y., Zhang, J., Tong, Y., Abbas, Z., Zhao, X., Li, Z., Zhang, H., Chen, S., Si, D., Zhang, R., & Wei, X. (2024). Peptide TaY Attenuates Inflammatory Responses by Interacting with Myeloid Differentiation 2 and Inhibiting NF-κB Signaling Pathway. Molecules. https://doi.org/10.3390/molecules29204843
Vancouver
Wang J, Zhou Y, Zhang J, Tong Y, Abbas Z, Zhao X, et al. Peptide TaY Attenuates Inflammatory Responses by Interacting with Myeloid Differentiation 2 and Inhibiting NF-κB Signaling Pathway. Molecules. 2024. doi:10.3390/molecules29204843
BibTeX
@article{Wang2024,
author = {Wang, Junyong and Zhou, Yichen and Zhang, Jing and Tong, Yucui and Abbas, Zaheer and Zhao, Xuelian and Li, Zhenzhen and Zhang, Haosen and Chen, Sichao and Si, Dayong and Zhang, Rijun and Wei, Xubiao},
title = {Peptide TaY Attenuates Inflammatory Responses by Interacting with Myeloid Differentiation 2 and Inhibiting NF-κB Signaling Pathway},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29204843}
}
EUVIMED